On the path to going global, JITAI BIOTECH has taken solid and remarkable steps.
On May 1, 2027, the official industry standard for blue copper peptide will come into force.
This standard clearly defines the purity control, impurity management, safety indicators and testing system of copper peptide products, establishing a unified "quality coordinate" for the entire industry. It effectively eliminates market chaos and drives the industry toward standardization and refinement. This milestone marks that China’s copper peptide industry has entered a new stage of higher-quality and more standardized development.
As the formulator of the blue copper peptide industry standard, JITAI BIOTECH has long adhered to a high-standard production system and strict quality management. We have continuously focused on improving the stability, consistency and application system of copper peptide raw materials, providing solid technical support and practical experience for the formulation and implementation of this standard.
Li Lun, General Manager of JITAI BIOTECH Group, stated: "Making Chinese standards become international standards is our belief and responsibility. The globalization of Chinese innovation and Chinese quality is not a gimmick for any enterprise; it requires joint efforts across the industry."

01 Innovative Ingredients Shine on the Global Stage
The in-depth development and application of functional peptide ingredients have long been embedded in JITAI BIOTECH’s corporate DNA.
Founded in 2013, we have been dedicated to the R&D, customization and production of peptide raw materials for skincare and pharmaceutical intermediates. The first peptide compound we successfully developed was blue copper peptide, and our first client was Dr. Loren Pickart, the renowned American biochemist and inventor of copper peptide. This deep connection with the global cosmetic ingredients industry laid the foundation for our presence on the world stage.
Driven by the wave of Chinese cosmetics going global, raw materials — the "chips" of products — have also stepped into global competition. With independent R&D and innovation capabilities, JITAI BIOTECH has become one of the few Chinese enterprises that have conquered the international arena.
In April this year, at in-cosmetics Global in Paris — the most influential exhibition for cosmetic and personal care ingredients worldwide — Janet Du, CEO of JITAI BIOTECH, was invited to deliver a keynote speech. She shared in-depth insights into the company’s structural innovation and industrialization achievements in functional peptides, attracting extensive attention and lively discussions among global industry peers. Our innovative ingredient APderma®CollaCyclic™ was also shortlisted for the Innovation Zone Best Ingredient Award.
 

This is not our first time shining internationally:
•    Our products have won the Special Contribution Award for Pharmaceutical R&D in Illinois, USA
•    Our innovative green synthesis process for cosmetic raw materials received the 2022 Cambridge Award (USA)
•    CEO Du Juan was honored as an Honorary Mentor of CACPA (Chinese-American Cosmetic Professionals Association)
Li Lun, Director and General Manager of JITAI BIOTECH Group, emphasized: "Win-win cooperation is inevitable for the industry. Only by competing and coexisting with peers and embracing a broad vision can we achieve sustainable development."

02 Six New Functional Peptides Cover Core Growth Segments
Continuous innovation is the core engine for raw material enterprises to maintain R&D vitality and business growth. In response to rapidly changing consumer demands, JITAI BIOTECH has been accelerating the innovative development of functional peptide ingredients and creating professional skincare solutions from the source.

Following international recognition in Paris, at the 2026 China Beauty Expo (CBE), we stood out as a spotlight exhibitor in the raw material hall with systematic functional peptide solutions, international product presentation and superior quality. Our core ingredients gained high recognition from brands, OEM/ODM enterprises and channel partners, resulting in numerous sample requests and cooperation intentions.

 
The highlight of the exhibition was our six functional peptide matrix, fully covering high-potential skincare segments including protection, repair, anti-aging and soothing. It provides downstream brands with complete formula upgrade paths and growth drivers, precisely matching differentiated needs:
1. HelioShield Peptides : Focuses on full-spectrum protection and photoaging management, targeting multi-dimensional light damage from UVA, UVB and blue light. Ideal for sunscreen and anti-aging product upgrades.
2. Chrono Sync Peptide: Built around skin circadian rhythm and periodic repair, emphasizing systematic repair and barrier stability. Suitable for high-end repair serums and functional creams.
3. PDRN-SignalBoost Peptide: Targets the regenerative repair trend with significantly improved repair efficiency. Perfect for post-medical treatment care, sensitive skin barrier repair and high-end anti-aging lines.
4. Micro Collagen Peptides: Focuses on collagen management and skin firmness & elasticity enhancement, aligning with core anti-aging values. Applicable for anti-wrinkle serums and firming creams.
5. Neurocosmetic Peptide: Caters to the neurocosmetics trend, specializing in soothing sensitivity and stress skin management. Designed for sensitive skin care and mood skincare products.
6. Splilanthol Series Peptides: Follows the natural skincare trend, balancing clean beauty and efficacy. Emphasizes safety and functional synergy of plant sources, meeting the market demand for "gentle + effective" solutions.
With  profound innovative raw material reserves, complete technical systems and outstanding market performance, JITAI BIOTECH won the 2026 CBE China Raw Material Award, further consolidating our leading position in China’s functional peptide raw material sector.

03 From Chinese Standards to Global Stage: Building a Global Functional Peptide Platform
According to Frost & Sullivan data:
•    In 2024, the global market size of cosmetic peptide raw materials reached $1.54 billion, with a CAGR of 12.1%.
•    China’s market size reached ¥2.17 billion, with a CAGR of 14.1%.
Peptide raw materials show strong growth potential in both global and domestic markets.
Since the implementation of the Cosmetics Supervision and Administration Regulation in 2021, 63 peptide-related raw materials have been registered (excluding cancelled ones) in China. The functional peptide sector is growing rapidly, yet high R&D requirements form a clear entry barrier — a core advantage of JITAI BIOTECH.
From leading the formulation of the blue copper peptide industry standard, speaking at Paris international exhibitions and being shortlisted for an international award, to impressing the industry at CBE and receiving top honors — JITAI BIOTECH is following the core strategy of platform-based technology, systematic products, standardized quality and globalized market. We are continuously building a future-oriented functional peptide innovation ecosystem and leading the high-quality development of China’s functional peptide industry.

Core Strength Supporting Global Layout
•    R&D Capabilities: Three R&D centers in Shanghai, Shandong and Boston (US), with a team of 50+ domestic and international PhDs. We own 300+ peptide products, 30+ customized raw materials and 12 authorized synthesis patents. Acetyl Dipeptide-1 has completed cosmetic new raw material registration (NO: 20240030) and entered the safety monitoring phase.
•    Large-scale Production: Peptide powder production plants and liquid peptide production bases, with 10-ton annual capacity for powder peptides and 1,000-ton annual capacity for liquid peptides, efficiently meeting diverse customer needs.
•    Strict Quality Management: ¥10 million invested in testing equipment, a 10+ biomedical-grade quality management team. Passed factory audits by international and top Chinese brands including Estée Lauder, Proya, Bloomage Biotech. Supported by a complete product traceability system, authoritative certifications and regular optimization to ensure full-process quality.
Going forward, JITAI BIOTECH will continue to increase R&D investment, deepen global layout, and serve global brands with forward-looking functional peptide solutions. We will continuously break through technical bottlenecks, establish a higher value coordinate for Chinese raw materials in the global market, and help China’s functional peptide industry move toward the center of the world stage.